A

AXONIS Therapeutics

16 employees

Axonis is advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Gene Therapy
Neuroprotection
Drug Discovery
Neuromodulation
Medical
Neuroregeneration

Date founded

2008

Funding rounds raised

Total raised

$5M

from 8 investors over 8 rounds

A

AXONIS Therapeutics raised $336K on September 24, 2022

Investors: National Institute of Neurological Disorders and Stroke (NINDS)

A

AXONIS Therapeutics raised $299K on September 1, 2022

Investors: National Eye Institute (NEI)

A

AXONIS Therapeutics raised $2.2M on March 1, 2022

Investors: National Institute of Neurological Disorders and Stroke (NINDS)

A

AXONIS Therapeutics raised $1.8M on February 14, 2022

Investors: united-states-department-of-defense

A

AXONIS Therapeutics raised $5M on July 14, 2021

Investors: BoxOne Ventures and Civilization Ventures

A

AXONIS Therapeutics raised $331K on September 30, 2020

Investors: National Institute of Neurological Disorders and Stroke (NINDS)

A

AXONIS Therapeutics raised $265K on January 14, 2020

Investors: Center for the Advancement of Science in Space

FAQ